Artificial intelligence recognizes heart disease by the sound of the voice

AI from a Berlin start-up is used for this purpose

06-Mar-2024 - Researchers at Charité's German Heart Center and the Mayo Clinic in the USA are conducting a new study to find out how patients with advanced heart failure can be monitored telemedically using the sound of their voice. Artificial intelligence from a Berlin start-up is being used for this. "Once ...

Genetic model identifies primary myelofibrosis outcomes

11-Dec-2017 - A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease. The group's findings ...

Mayo Clinic researchers map prostate cancer relapse

By using C-11 choline PET and MRI

05-Oct-2016 - A team of Mayo Clinic researchers has, for the first time, successfully mapped patterns of prostate cancer recurrence, following surgery. Using C-11 choline PET imaging and multiparametric MRI, researchers found an anatomically diverse pattern of recurrence, which may help optimize treatment of ...

Scientists and NASA astronauts developing near real-time osteoporosis and bone cancer test

19-Aug-2015 - A new test for offers the possibility of near real time monitoring of bone diseases, such as osteoporosis and multiple myeloma. The functionality of the test, which measures changes in calcium isotope ratios, has been validated on blood samples from NASA space shuttle astronauts. Geochemists have ...

Targeted screening for C. difficile upon hospital admission could potentially identify most colonized patients

03-May-2013 - Testing patients with just three risk factors upon hospital admission has potential to identify nearly three out of four asymptomatic carriers of C. difficile, according to a new study published in the May issue of the American Journal of Infection Control.Researchers from Mayo Clinic in ...

Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease

Results Predict Likelihood and Age of Disease Onset, May Lead to Risk-Assessment Tests

20-Jun-2007 - Gene Logic Inc. announced that a collaborative study between its Genomics Division and Mayo Clinic has found biomarkers that predict susceptibility to Parkinson's disease and age of disease onset. The study was novel in its detailed and comprehensive analysis of genes and their polymorphic ...